{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:52:07Z","timestamp":1740153127815,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13052-017-0421-5","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T12:26:03Z","timestamp":1510921563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report"],"prefix":"10.1186","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-3712","authenticated-orcid":false,"given":"Alvise","family":"Tosoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cutrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Dalle Carbonare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Pettenazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Perilongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,17]]},"reference":[{"issue":"4","key":"421_CR1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2015.13969","volume":"315","author":"S Prey","year":"2016","unstructured":"Prey S, Voisard JJ, Delarue A, Lebbe G, Taieb A, Leaute-Labreze C, et al. Safety of Propranolol therapy for severe infantile Hemangioma. JAMA. 2016;315(4):413\u20135.","journal-title":"JAMA"},{"issue":"7","key":"421_CR2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00431-015-2570-0","volume":"174","author":"PH Hoeger","year":"2015","unstructured":"Hoeger PH, Harper JI, Baselga E, Bonnet D, Boon LM, Ciofi Degli Atti M, et al. Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr. 2015;174(7):855\u201365.","journal-title":"Eur J Pediatr"},{"issue":"8-9","key":"421_CR3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.annder.2014.04.111","volume":"141","author":"W Saidi","year":"2014","unstructured":"Saidi W, Zaouali A, Saihi N, Mokni S, Denguezli M, Nouira R. Cardiorespiratory arrest following bronchiolitis in a child treated with propranolol for hemangioma. Annales de dermatologie et de venereologie. 2014;141(8-9):528\u20139.","journal-title":"Annales de dermatologie et de venereologie"},{"issue":"8","key":"421_CR4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C Leaute-Labreze","year":"2015","unstructured":"Leaute-Labreze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735\u201346.","journal-title":"N Engl J Med"},{"issue":"4","key":"421_CR5","doi-asserted-by":"crossref","first-page":"e1060","DOI":"10.1542\/peds.2015-2485","volume":"136","author":"DH Darrow","year":"2015","unstructured":"Darrow DH, Greene AK, Mancini AJ, Nopper AJ, Section On Dermatology SOO-H, Neck S, et al. Diagnosis and Management of Infantile Hemangioma. Pediatrics. 2015;136(4):e1060\u2013104.","journal-title":"Pediatrics"},{"key":"421_CR6","doi-asserted-by":"crossref","unstructured":"Leaute-Labreze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390(10089):85\u201394.","DOI":"10.1016\/S0140-6736(16)00645-0"},{"key":"421_CR7","doi-asserted-by":"crossref","unstructured":"Metry DW. S Infantile hemangiomas: Management. Corona R, ed. UpToDate. Waltham, MA: UpToDate Inc. http:\/\/www.uptodate.com . Accessed 28 Sept 2017.","DOI":"10.1097\/01.EEM.0000527825.59509.f5"},{"issue":"1","key":"421_CR8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.braindev.2014.02.004","volume":"37","author":"S Sartori","year":"2015","unstructured":"Sartori S, Nosadini M, Leoni L, de Palma L, Toldo I, Milanesi O, et al. Pacemaker in complicated and refractory breath-holding spells: when to think about it? Brain Dev. 2015;37(1):2\u201312.","journal-title":"Brain Dev"},{"issue":"3","key":"421_CR9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1542\/peds.108.3.698","volume":"108","author":"AM Kelly","year":"2001","unstructured":"Kelly AM, Porter CJ, McGoon MD, Espinosa RE, Osborn MJ, Hayes DL. Breath-holding spells associated with significant bradycardia: successful treatment with permanent pacemaker implantation. Pediatrics. 2001;108(3):698\u2013702.","journal-title":"Pediatrics"},{"issue":"4","key":"421_CR10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/pch\/7.4.251","volume":"7","author":"LM Legge","year":"2002","unstructured":"Legge LM, Kantoch MJ, Seshia SS, Soni R. A pacemaker for asystole in breath-holding spells. Paediatr Child Health. 2002;7(4):251\u20134.","journal-title":"Paediatr Child Health"},{"issue":"6","key":"421_CR11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/j.1875-9114.1997.tb03097.x","volume":"17","author":"KM Sowinski","year":"1997","unstructured":"Sowinski KM, Burlew BS. Impact of CYP2D6 poor metabolizer phenotype on propranolol pharmacokinetics and response. Pharmacotherapy. 1997;17(6):1305\u201310.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"421_CR12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/clpt.1989.11","volume":"45","author":"SA Ward","year":"1989","unstructured":"Ward SA, Walle T, Walle UK, Wilkinson GR, Branch RA. Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities. Clin Pharmacol Ther. 1989;45(1):72\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"421_CR13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/hmg\/ddt417","volume":"23","author":"D Wang","year":"2014","unstructured":"Wang D, Poi MJ, Sun X, Gaedigk A, Leeder JS, Sadee W. Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity. Hum Mol Genet. 2014;23(1):268\u201378.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"421_CR14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13052-017-0357-9","volume":"43","author":"M El Hachem","year":"2017","unstructured":"El Hachem M, Gesualdo F, Diociaiuti A, Berti I, Vercellino N, Boccaletti V, et al. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience. Ital J Pediatr. 2017;43(1):40.","journal-title":"Ital J Pediatr"},{"issue":"3","key":"421_CR15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/pde.12520","volume":"32","author":"GV Vivas-Colmenares","year":"2015","unstructured":"Vivas-Colmenares GV, Bernabeu-Wittel J, Alonso-Arroyo V. Matute de Cardenas JA, Fernandez-Pineda I. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase. Pediatr Dermatol. 2015;32(3):348\u201352.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"421_CR16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/1516-3180.2014.1321575","volume":"132","author":"JC Albuquerque","year":"2014","unstructured":"Albuquerque JC, Magalhaes RA, Felix JA, Bastos MV, Fontenele JB, Trompieri NM, et al. Treatment of children and adolescents with hemangioma using propranolol: preliminary results from a retrospective study. Sao Paulo medical journal = Revista paulista de medicina. 2014;132(1):48\u201354.","journal-title":"Sao Paulo medical journal = Revista paulista de medicina"},{"issue":"2","key":"421_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1525-1470.2010.01379.x","volume":"28","author":"A Zvulunov","year":"2011","unstructured":"Zvulunov A, McCuaig C, Frieden IJ, Mancini AJ, Puttgen KB, Dohil M, et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr Dermatol. 2011;28(2):94\u20138.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"421_CR18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s40800-015-0009-1","volume":"2","author":"AD Pratico","year":"2015","unstructured":"Pratico AD, Caraci F, Pavone P, Falsaperla R, Drago F, Ruggieri M. Propranolol: effectiveness and failure in infantile Cutaneous Hemangiomas. Drug safety - case reports. 2015;2(1):6.","journal-title":"Drug safety - case reports"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-017-0421-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T19:04:55Z","timestamp":1719601495000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-017-0421-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,17]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["421"],"URL":"https:\/\/doi.org\/10.1186\/s13052-017-0421-5","relation":{},"ISSN":["1824-7288"],"issn-type":[{"type":"electronic","value":"1824-7288"}],"subject":[],"published":{"date-parts":[[2017,11,17]]},"article-number":"103"}}